Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection

BACKGROUND: Severe cases of Coronavirus Disease 2019 (COVID-19) that require admission to the Intensive Care Unit (ICU) and mechanical ventilation assistance show a high mortality rate with currently few therapeutic options available. Severe COVID-19 is characterized by a systemic inflammatory condi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elizagaray, Maia Lina, Mazitelli, Ignacio, Pontoriero, Andrea, Baumeister, Elsa, Docena, Guillermo, Raimondi, Clemente, Correger, Enrique, Rumbo, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chang Gung University 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357286/
https://www.ncbi.nlm.nih.gov/pubmed/35948250
http://dx.doi.org/10.1016/j.bj.2022.07.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357286/
https://www.ncbi.nlm.nih.gov/pubmed/35948250
http://dx.doi.org/10.1016/j.bj.2022.07.008

Ejemplares similares